Gene · 1725
Papers1,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disparate co-evolution and prevalence of sulfadoxine and pyrimethamine resistance alleles and haplotypes at dhfr and dhps genes across Africa. | Sci Rep | 2025 | 40247054 | PubTator, text mining | PubMed |
| Prevalence of antimalaria drug resistance-conferring mutations associated with sulphadoxine-pyrimethamineine-resistant Plasmodium falciparum in East Africa: a systematic review and meta-analysis. | Ann Clin Microbiol Antimicrob | 2025 | 40241183 | PubTator, text mining | PubMed |
| Very low prevalence of validated kelch13 mutations and absence of hrp2/3 double gene deletions in South African malaria-eliminating districts (2022-2024). | medRxiv | 2025 | 40236387 | PubTator, text mining | PubMed |
| CONSTRUCT: an algorithmic tool for identifying functional or structurally important regions in protein tertiary structure. | Bioinformatics | 2025 | 40220324 | PubTator, text mining | PubMed |
| Spermidine restricts neonatal inflammation via metabolic shaping of polymorphonuclear myeloid-derived suppressor cells. | J Clin Invest | 2025 | 40166929 | PubTator, text mining | PubMed |
| Investigating the dynamics of Plasmodium falciparum gametocyte carriage in expectant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Kilifi, study protocol. | Open Res Eur | 2025 | 40135107 | PubTator, text mining | PubMed |
| Development of a reliable, sensitive, and convenient assay for the discovery of new eIF5A hypusination inhibitors. | PLoS One | 2025 | 39937781 | PubTator, text mining | PubMed |
| Synthesis, antibacterial and anticancer activity of azo-based and aminomethylene derivatives of cyclic β-keto sulfones. | Bioorg Med Chem Lett | 2025 | 39892468 | PubTator, text mining | PubMed |
| Monitoring molecular markers associated with antimalarial drug resistance in south-east Senegal from 2021 to 2023. | J Antimicrob Chemother | 2025 | 39846779 | PubTator, text mining | PubMed |
| The structural biology of deoxyhypusination complexes. | Structure | 2025 | 39809274 | PubTator, text mining | PubMed |
| Knockout or inhibition of DHPS suppresses ovarian tumor growth and metastasis by attenuating the TGFβ pathway. | Sci Rep | 2025 | 39762448 | PubTator, text mining | PubMed |
| Application of a new highly multiplexed amplicon sequencing tool to evaluate Plasmodium falciparum antimalarial resistance and relatedness in individual and pooled samples from Dschang, Cameroon. | Front Parasitol | 2024 | 39975479 | PubTator, text mining | PubMed |
| Analysis of Mutations in Pneumocystis jirovecii Dihydropteroate Synthase and Dihydropteroate Reductase Genes Among Non-HIV Patients in China. | Infect Drug Resist | 2024 | 39711828 | PubTator, text mining | PubMed |
| Hypusination in intestinal epithelial cells protects mice from infectious colitis. | Gut Microbes | 2024 | 39673545 | PubTator, text mining | PubMed |
| Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine-pyrimethamine five years (2016-2020) after the implementation of seasonal malaria chemoprevention in Cameroon. | Wellcome Open Res | 2024 | 39649624 | PubTator, text mining | PubMed |
| Corrigendum to "Novel deoxyhypusine synthase (DHPS) inhibitors target hypusination-induced vasculogenic mimicry (VM) against malignant melanoma" Pharmacol. Res. 209 (November) (2024) 107453. | Pharmacol Res | 2024 | 39603849 | PubTator, text mining | PubMed |
| Profile of molecular markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo. | Int J Parasitol Drugs Drug Resist | 2024 | 39488015 | PubTator, text mining | PubMed |
| ONT sequencing identifies a high prevalence of crt sensitive, triple mutant dhfr and single mutant dhps parasites within an ANC population in Nigeria. | Front Genet | 2024 | 39483850 | PubTator, text mining | PubMed |
| Research on performance and potential of distributed heating system for peak shaving with multi-energy resource. | Sci Rep | 2024 | 39455663 | PubTator, text mining | PubMed |
| ERK1/2 interaction with DHPS regulates eIF5A deoxyhypusination independently of ERK kinase activity. | Cell Rep | 2024 | 39392755 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1725/papers?page=4